Price reduction of medical service equipment

With the reform of the national medical system, many very expensive drugs in China have become cheaper, but people's surgery is also the focus of medical consumption. In order to deepen the reform, the state has made centralized procurement in the field of high-value medical consumables, among which the heart stent has been reduced from 6,543,800 yuan to 0.3 million yuan in 700 yuan, which has attracted many netizens' comments. I think the decline in the price of cardiac stents will help to reduce the burden on patients and make them spend less on medical care. The decline in the price of heart stents will reduce over-medical treatment, and doctors will no longer advise patients to do heart stents for the benefit. The low price of cardiac stents may reduce the enthusiasm of medical device manufacturers.

First, the decline in the price of heart stents can reduce the burden on patients and make them spend less money on medical care. People are now expensive to see a doctor because of the high price of medical equipment and drugs, and the price of heart stents has dropped from more than 10 thousand to several hundred dollars. The cost of people who perform surgery has been reduced a lot at once, and many patients can reduce their burden and spend less money when performing surgery. The reduction in the price of cardiac stents will benefit these patients, and in the future, patients will also reduce this part of the cost and reduce economic pressure.

Second, the decline in the price of heart stents will reduce over-medical treatment, and doctors will no longer recommend patients to do heart stents for the benefit. The widespread use of cardiac stents is inseparable from the surgery recommended by doctors. Now many hospital departments are independent accounting. In order to earn more income, many patients overtreate. After the price of heart stent drops, doctors will no longer recommend patients for heart stent surgery because of their interests, so the situation of overtreatment will be reduced, and many people can recover slowly without surgery.

Third, the low price of cardiac stents may reduce the enthusiasm of cardiac stent manufacturers. If the price of heart stent drops, the manufacturer of heart stent will have no profit. If there is no profit in commercial activities, their enthusiasm for production will decline, which is likely to reduce the supply of heart stents. Therefore, to carry out medical reform, we can't just cut prices. Follow-up production should be prepared in advance.

How to treat the price reduction of heart stent? Please leave a message for discussion.